Novavax
NVAX
#5100
Rank
$1.77 B
Marketcap
$10.78
Share price
10.22%
Change (1 day)
51.62%
Change (1 year)

EPS for Novavax (NVAX)

EPS in 2023 (TTM): -$7.19

According to Novavax's latest financial reports the company's current EPS (TTM) is -$1.52. In 2022 the company made an earnings per share (EPS) of -$8.30 an increase over its 2021 EPS that were of -$23.29.

EPS history for Novavax from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.19-13.37%
2022-$8.30-64.36%
2021-$23.29243%
2020-$6.7919.75%
2019-$5.67-43.86%
2018-$10.10-19.84%
2017-$12.60-38.83%
2016-$20.6074.58%
2015-$11.8063.89%
2014-$7.2016.13%
2013-$6.2040.91%
2012-$4.4029.41%
2011-$3.40-50%
2010-$6.80-27.66%
2009-$9.40-11.32%
2008-$10.60-7.02%
2007-$11.4046.15%
2006-$7.8050%
2005-$5.20-63.38%
2004-$14.2020.34%
2003-$11.80-35.87%
2002-$18.40113.95%
2001-$8.60-33.85%
2000-$13.00109.68%
1999-$6.20-40.38%
1998-$10.4030%
1997-$8.00-9.007199254741E+17%
1996$0.0000000000

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
$5.25-445.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$0.76-150.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$6.68-539.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$2.88-289.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-$2.63 73.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-$4.35 186.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
$2.02-232.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-$0.44-71.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-$1.44-5.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-$3.44 126.32%๐Ÿ‡บ๐Ÿ‡ธ USA